Home・Aandelen Lijst・Ocugen Inc

Ocugen Inc

Gesloten

1.06 3.92

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

Max

1.08

Belangrijke statistieken
By Trading Economics
Inkomsten	-5.7M -25M
Verkoop	-45K 1.5M
EPS	-0.07
Winstmarge	-1,671.841
Werknemers	116
EBITDA	-2.5M -20M

Aanbevelingen
By TipRanks
Aanbevelingen	Strong Buy
12 Maanden Prognose	+883.01% upside

Dividenden
By Acuity
Volgende Winsten	4 nov 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-57M 359M
Vorige openingsprijs	-2.86
Vorige sluitingsprijs	1.06

Ocugen Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

18 sep 2026, 23:56 UTC

Packaging Corp of America is trading modestly higher in after-market hours, despite unchanged U.S. industrial production and a decline in manufacturing output.

18 sep 2026, 23:56 UTC

Below 20-day average, near one-month range in after-market hours.

18 sep 2026, 23:55 UTC

Extreme Networks Inc is trading modestly higher in after-market hours, reflecting typical performance within its one-month range following Friday's close.

18 sep 2026, 23:55 UTC

Lumen Technologies Inc is trading modestly higher in after-market hours, rebounding from earlier lows amid a broader trend of five consecutive lower daily closes.

18 sep 2026, 23:55 UTC

Edison International is trading modestly higher in after-market hours, gradually advancing since Friday's close but remains below its 20-day moving average.

18 sep 2026, 23:52 UTC

Mosaic Co is trading modestly higher in after-hours activity, maintaining a position approximately 1.36% below its 20-day moving average.

18 sep 2026, 23:52 UTC

Grab Holdings Ltd is trading lower in after-market hours, reaching its lowest price of the day and remaining significantly below its 20-day moving average.

18 sep 2026, 23:52 UTC

Correlated Moves

Jabil Inc is advancing in after-market trading, reflecting a significant rise since Friday's close and aligning with gains in the iShares Dynamic Equity Active ETF.

18 sep 2026, 23:52 UTC

Generac Holdings Inc is seeing a modest increase in after-market trading, aligning with broader market trends despite stagnation in U.S. industrial production data for August.

18 sep 2026, 23:51 UTC

Pacific Biosciences of California Inc declined during after-market trading, moving lower since Friday's close and currently below its 20-day moving average.

18 sep 2026, 23:51 UTC

Ribbon Communications Inc is declining in after-market trading, moving lower since Friday's close and trading well below its 20-day moving average.

18 sep 2026, 23:51 UTC

Amphenol Corp is gaining in after-market trading, reaching a notable high since Friday's close, despite remaining below its 20-day moving average.

18 sep 2026, 23:51 UTC

Lincoln National Corp is trading modestly higher in after-market hours, influenced by broader market gains amid ongoing geopolitical tensions and mixed economic data.

18 sep 2026, 23:51 UTC

Kyndryl Holdings Inc is moving higher in after-market trading, supported by broader market trends, despite stagnation in U.S. industrial production data for August.

18 sep 2026, 23:51 UTC

Correlated Moves

Microchip Technology Inc. is trading modestly lower in after-market hours, following a decline from earlier gains amid a broader downturn in the semiconductor sector.

18 sep 2026, 23:51 UTC

Correlated Moves

Southern Copper Corp is trading modestly lower in after-market hours, continuing a trend observed throughout the day, amid stable performance from the NYLIM FTSE ETF.

18 sep 2026, 23:51 UTC

EHang Holdings Ltd shows notable strength in after-market trading, advancing significantly from earlier lows despite remaining near the lower end of its one-month trading range.

18 sep 2026, 23:51 UTC

Cleveland-Cliffs Inc declined in after-market trading but remains above its 20-day moving average and near the upper end of its one-month range.

18 sep 2026, 23:51 UTC

Charter Communications Inc is rising in after-market trading, reaching its highest cumulative return since Friday's close, reversing a trend of recent declines.

18 sep 2026, 23:51 UTC

Event

Paychex Inc is trading higher in after-market hours ahead of its Q1 FY2027 earnings report, with EPS estimated at $1.32 and revenue at $1.6 billion.

18 sep 2026, 23:51 UTC

Devon Energy Corp's shares are modestly higher during after-market hours, currently positioned around the middle of their one-month trading range.

18 sep 2026, 23:51 UTC

Correlated Moves

Pfizer Inc is trading lower in after-market hours, reflecting a decline since Friday's close, influenced by Bristol-Myers Squibb's recent performance.

18 sep 2026, 23:51 UTC

American Electric Power Company Inc is trading modestly higher in after-market hours, recovering from earlier lows but remains below its 20-day moving average.

18 sep 2026, 23:51 UTC

Tractor Supply Co is seeing a modest increase in after-market trading, recovering from an earlier dip amid stagnation in U.S. industrial production.

18 sep 2026, 23:51 UTC

Kinder Morgan Inc is declining in after-market trading, having reached its lowest point of the day after fluctuating sharply during the session.

18 sep 2026, 23:46 UTC

Lamb Weston Holdings Inc is trading modestly higher in after-market hours, recovering from a low point shortly after the market closed.

18 sep 2026, 23:46 UTC

BRC Group Holdings Inc is trading modestly higher in after-market hours, despite a notable decline from earlier gains during the session.

18 sep 2026, 23:46 UTC

Tripadvisor Inc's stock advanced in after-market trading, fluctuating between a low of 0.06% and a high of 1.19% since Friday's close.

18 sep 2026, 23:46 UTC

Correlated Moves

Portland General Electric Co is trading modestly higher in after-market hours, reflecting broader gains in the Electric Utilities sector alongside Alliant Energy Corp.

18 sep 2026, 23:46 UTC

Viavi Solutions Inc is seeing modest gains in after-market trading, recovering from earlier fluctuations that pulled the stock back from a session high.

Peer Vergelijking

Prijswijziging

Ocugen Inc Prognose

Koersdoel

By TipRanks

883.01% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 10.125 USD 883.01%

Hoogste 12 USD

Laagste 8 USD

Gebaseerd op 4 Wall Street-analisten die 12-maands prijsdoelen bieden voor Ocugen Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

4 ratings

Buy

Hold

Sell

Gebaseerd op 4 analisten die aandelenratings hebben gegeven aan Ocugen Inc - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.